PARTNER NEWS:Wed, Feb 28, 6:41 AM, Zacks
Esperion (ESPR) Q4 Earnings Top, Stock Up on Strong Revenues Esperion's (ESPR) fourth-quarter earnings and sales beat estimates on the back of better-than-expected collaboration revenues.
Tue, Feb 27, 6:20 AM, Zacks
Esperion Therapeutics (ESPR) Reports Q4 Loss, Tops Revenue Estimates Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 5.66% and 20.16%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Featured MNV Articles: ZYME Crosses Below Key Moving Average Level
Wednesday, April 17, 4:49 PM ET, by Market News Video Staff
In trading on Wednesday, shares of Zymeworks Inc (ZYME) crossed below their 200 day moving ...
WVE Crosses Below Key Moving Average Level
Wednesday, April 17, 4:49 PM ET, by Market News Video Staff
In trading on Wednesday, shares of Wave Life Sciences Ltd (WVE) crossed below their 200 ...
Notable Two Hundred Day Moving Average Cross - SUPN
Wednesday, April 17, 4:45 PM ET, by Market News Video Staff
In trading on Wednesday, shares of Supernus Pharmaceuticals Inc (SUPN) crossed below their 200 day ...
Paychex Breaks Below 200-Day Moving Average - Notable for PAYX
Wednesday, April 17, 4:43 PM ET, by Market News Video Staff
In trading on Wednesday, shares of Paychex Inc (PAYX) crossed below their 200 day moving ...
Relative Strength Alert For Apellis Pharmaceuticals
Wednesday, April 17, 4:42 PM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
|
|
By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
|